ABSTRACT We identified 420 medically treated and 231 surgically treated patients (coronary graft plus myocardial surgery in 30%) who had severe left ventricular dysfunction manifest by an ejection fraction below 0.36 and markedly abnormal wall motion. Compared with medically treated patients, those treated surgically had more severe angina (56.7% vs 29.0% class III or IV; p < .001), less heart failure as predominant symptom (I 1. 1% vs 18.8%; p < .003), more severe coronary disease (66.7% vs 50.2% three-vessel disease; p < .001), a greater concentration of left main coronary artery lesions > 70% (12.6% vs 3.8%: p < .001), and a greater estimated extent of jeopardized myocardium (p < .001). Multivariate regression analysis of survival, which adjusts for the above covariates, showed that surgical treatment prolonged survival (p < .05), although it ranked below severity of heart failure symptoms, age, ejection fraction, and left main stenosis >70% in determining prognosis. Surgical benefit was most apparent for patients with ejection fractions below 0.26 who had a 43% 5 year survival with medical treatment vs 63% with surgery. Surgically treated patients experienced substantial symptomatic benefit compared with medically treated patients if their presenting symptoms were predominantly angina; however, there was no relief of symptoms caused primarily by heart failure. We conclude that patients with predominantly ischemic pain symptoms, despite poor left ventricular function, benefit from surgery; however, operative mortality in this high-risk subset must equal or better the 6.9% obtained in this study. Circulation 68, No. 4, 785-795, 1983. MANY STUDIES have examined the role of coronary surgery in patients with disabling symptoms, advanced coronary vascular lesions, and relatively well-retained myocardial function. However, for patients who have significant left ventricular dysfunction, concerns about increased operative mortality, diminished long-term survival, and irreversibility of myocardial scar have made it difficult to assess the role of coronary surgery in these patients. The NHLBI-sponsored Coronary Artery Surgery Study (CASS) Registry, which enrolled patients from 1974 to 1979, includes many patients with left ventricular dysfunction whose management varied according to local physicians' preferences based on their assessment of patient symptoms and angiographic findings. We retrospectively reviewed those patients who fell below a specific threshold of left ventricular dysfunction and sought to evaluate those variables that determine survival, coronary events, and symptomatic status. 
MANY STUDIES have examined the role of coronary surgery in patients with disabling symptoms, advanced coronary vascular lesions, and relatively well-retained myocardial function. However, for patients who have significant left ventricular dysfunction, concerns about increased operative mortality, diminished long-term survival, and irreversibility of myocardial scar have made it difficult to assess the role of coronary surgery in these patients. The NHLBI-sponsored Coronary Artery Surgery Study (CASS) Registry, which enrolled patients from 1974 to 1979, includes many patients with left ventricular dysfunction whose management varied according to local physicians' preferences based on their assessment of patient symptoms and angiographic findings. We retrospectively reviewed those patients who fell below a specific threshold of left ventricular dysfunction and sought to evaluate those variables that determine survival, coronary events, and symptomatic status.
From the Cardiology Division, Stanford University Medical Center, Stanford, CA. specific selection criteria were randomized into medical and surgical treatment groups. Because randomization excluded patients with poor left ventricular function (usually ejection fractions below 36%), this study focuses on nonrandomized registry patients who had left ventricular dysfunction defined as a combination of an ejection fraction less than or equal to 35% and a left ventricular wall motion score greater than or equal to 12 (definition given in next section). We imposed this simultaneous requirement for an abnormal ejection fraction and abnormal wall motion score to ensure concurrence of an objective measurement usually made by a technician (ejection fraction) and a qualitative assessment of wall motion made by the angiographer. We also required that patients have no history of prior coronary surgery or mitral regurgitation of moderate or severe degree; our patients were not included within the subset of randomized CASS patients. Patients were required to have a coronary lesion of 70% or greater in at least one major artery and to have completed a minimum of 1 year follow-up.
Variables included in the study. Table 1 is a complete list of the variables included in this study. The severity of angina was categorized according to the Canadian Heart Association classification.2 Class I angina occurs only with strenuous, rapid, or prolonged exertion, whereas angina of class IV severity prevents the patient from doing any activity without developing angina. The distinction between intermediate classes II and III depends on whether the patient can walk two blocks or climb one flight of stairs under ordinary temperature or wind conditions. Congestive heart failure (CHF) symptoms were categorized by four levels of severity in accordance with the extent of functional limitation of the patient (none, mild, moderate, or severe). Other clinical variables included angina as the primary symptom, CHF as the primary symptom, and use of digitalis or diuretics. In addition, a CHF score was used, which included the number of positive responses to history of CHF, digitalis use, diuretic use, and the presence of rales (total possible score: 0 to 4).
The number of diseased arteries (one to three) was based on whether the right coronary artery, left anterior descending artery, or circumflex vessel in their major segments or major branches contained lesions greater than or equal to 70% or whether the left main segment contained a lesion of 50% or more. Determination of the number of operable arteries (range zero to three) depended on both the location of lesions and the morphologic appearance of vessels distal to the lesions, with the requirement that the distal vessel be sufficiently well visualized and of adequate size to be a graft recipient. The 
Results
The distribution of clinical characteristics of the 420 medically treated and 231 surgically treated patients is shown in tables 2 and 3. Significant differences between the two groups were based on chi-square statistics for discrete variables and F-test statistics for continuous variables. There were no significant differences between the two groups with regard to age, functional impairment caused by heart failure, digitalis use, diuretic use, left ventricular end-diastolic pressure, or presence of left ventricular aneurysm on angiography.
There was, however, a distinct concentration of patients with angina as the primary symptom in the surgical group as compared with the medical group. Conversely, patients with predominant heart failure symptoms were concentrated in the medical group. Moreover, surgically treated patients tended to have more severe coronary vascular disease, with 66.7% having three-vessel disease vs 50.2% in the medical group (p < .001). Similarly, 12 .6% of the 231 surgically treated patients had left main lesions greater or equal to 70% vs 3.8% in the medical group (p < .001). The medically treated patients had somewhat lower ejection fractions and worse wall motion scores compared with surgically treated patients. The medically treated patients also had significantly fewer myocardi- a comparison of survival for all 651 patients adjusted for ejection fraction terciles, whereas figures 1B, IC, and ID show survival curves for patients in the upper, middle, and lower terciles of ejection fractions at or below 35%. The 5 year survival of medically treated patients ranged from 64% for patients in the upper tercile (ejection fraction between 31% and 35%) to 41% for patients with ejection fractions at or below 25%. A statistically significant difference determined by the log rank method between surgical and medical treatment was present for the combination of all three terciles (p = .0007, figure lA) and for the lowest tercile (p = .0056, figure ID) .
All patients have been followed up at annual intervals for a mean follow-up time of 3.7 years. Twotenths of 1% of patients have been lost to follow-up and 9.3% of the medically treated patients have had coronary surgery more than 90 days after angiography. At the time of 3 year follow-up, 30.2% of surgically treated and 9.8% of medically treated patients whose primary presenting symptom was chest pain became free of functional limitation. In those patients who were still experiencing some degree of functional limitation, angina was the responsible factor in 49.3% of the medically treated patients and 19.0% of the surgically treated patients. Thirty-two percent of the medically treated patients had died vs 16% of the surgically treated patients. The three leading clinical syndromes associated with death were, in rank order, sudden death, myocardial infarction, and heart failure for medically treated patients, whereas the ranking for surgery patients was heart failure, shock, and arrhythmia.
CIRCULATION
For patients whose primary limitation was dyspnea or fatigue, the percentages of patients dead at 3 years were the same for medical and surgical treatment (45.2% medical vs 45.2% surgical). The three leading clinical syndromes associated with death for both medical and surgical patients were, in rank order, heart failure, sudden death, and arrhythmia. Only 5.8% of the medically treated patients and 6.4% of the surgically treated patients were free of functional limitation at the time of 3 patients with heart failure as the predominant presenting symptom (NS).
Discussion
The results of this study suggest that coronary surgery is beneficial in patients with severe left ventricular dysfunction, not only in promoting their survival but also in improving their functional status. This benefit of surgery was partially confined to patients who had angina as the predominant symptom. Al-
though it is commonly considered that patients with the lowest ejection fractions are at greater risk for surgical complications and mortality,5 this study points out that the long-term benefits of surgery outweigh the somewhat increased short-term hazards. The fact that the lowest ejection fraction terciles of patients ( figure 1D ) showed statistical benefit compared with the other terciles reflects the greater ease of demonstrating a beneficial effect when event frequency in the control group is high. It is possible that a larger number of patients in N CUMULATIVE SURVIVAL: ejecfr 3 This result implies that therapeutic interventions directed at left ventricular aneurysms would not have important prognostic significance. This indeed is the conclusion that can be derived from the regression analysis noted in table 5 (analysis 2), in which myocardial surgery in patients with left ventricular aneurysm had no beneficial effect on survival. Moreover, the fact that symptomatic benefit was primarily restricted to patients with angina suggests that myocardial resection -did not help patients with predominant heart failure symptoms.
The specific criteria that the surgeons used to determine whether resection or plication would be added to the bypass graft procedure were not defined by the CASS protocol. The fact that a substantial portion of patients undergoing aneurysm or plication surgery did not have a discrete aneurysm noted on ventriculography is an indication of the heterogeneity of approaches used in the management of abnormal myocardial segments at the time of surgery. Certainly questions might be raised regarding the extent to which myocardial surgery should be added to coronary bypass (30.3% in this study), particularly when one considers that it constitutes a threefold increase in univariate relative risk for operative mortality.'2 However, left ventricular aneurysmectomy was not an independent operative risk factor by multivariate analysis. 13 In years past, the elevated operative risk of patients with severe left ventricular dysfunction has led to 794 medical management of such patients, even when considerable angina was the presenting complaint. ' 22 in retrospective comparisons of medically and surgically treated patients. These reports and those of others23-26 all suggest that myocardial revascularization in patients with angina as the primary symptom can be accomplished with significant benefit for the patient.
It remains controversial regarding the extent to which silent ischemic left ventricular dysfunction may be present in patients with low ejection fractions, thus accounting for a beneficial effect from revascularization. At the time of the baseline left ventriculogram it is also possible that some patients have active ischemia with accompanying wall motion abnorrnalities that do not necessarily reflect prior infarction and fibrosis, but rather active ischemia. Radionuclide studies performed 2 weeks postoperatively by Hellman et al.27 did demonstrate a beneficial effect on ejection fraction; however, increased adrenergic tone, as demonstrated by substantially higher heart rates, probably accounts for these findings. Hung et al.28 performed radionuclide scans in 18 of 20 survivors at 19 months and showed benefit on ejection fraction only in six patients who had left main coronary lesions. Certainly the fact that operative benefit was more notable in patients with ischemic symptoms, in contrast with heart failure symptoms, supports the hypothesis that myocardial fibrosis underlying heart failure symptoms is not reversible by surgery. However, predominantly ischemic symptoms implies the presence ofjeopardized yet potentially viable myocardium and it is these patients who exhibit the most prominent clinical benefit. Moreover, the fact that the leading clinical syndromes associated with death in patients whose major presenting complaint was ischemic pain shifted from sudden death, infarction, and heart failure in medically treated patients to heart failure, shock, and arrhythmia in surgically treated patients implies that benefit in survival resulted from infarct prevention rather than restoration of hemodynamic function.
In conclusion, our results suggest that patients with overt heart failure and the absence of ischemic symp-toms should not receive surgery. However, patients with angina as the predominant symptom, although having poor ventricular function, should not be excluded from coronary surgery despite higher operative risk and prolonged hospitalization. In fact, our results suggest that survival and relief of symptoms will be substantially benefited.
An important caveat regarding these conclusions is that the surgery and associated diagnostic and postoperative care must be of sufficient quality to result in an operative mortality rate at or below the range defined in this study. Cardiac surgery in this group of patients should not be undertaken in centers in which operative mortality statistics are marginal or in which complete facilities for management of complex postoperative problems cannot be provided.
